Angiotensin II Modulates Podocyte Glucose Transport

Area of Science:

• Nephrology
• Endocrinology
• Molecular Biology

Background:

• Podocytes are crucial for kidney filtration and are affected by Angiotensin II (AngII).
• AngII signaling contributes to podocyte dysfunction in kidney diseases like diabetic nephropathy.

Purpose of the Study:

• To investigate how AngII influences glucose uptake in mouse podocytes under normal and high glucose conditions.
• To understand the role of AngII in regulating glucose transporters and insulin signaling in podocytes.

Main Methods:

• Mouse podocytes expressing human AT1 receptor were cultured in normal (NG) or high glucose (HG).
• Cells were exposed to AngII for short (30 min) and long-term (24 h) periods.
• Glucose uptake, transporter expression (GLUT1, GLUT2, GLUT4), and insulin receptor levels were measured.

Main Results:

• AngII significantly enhanced basal glucose uptake in podocytes under both NG and HG conditions.
• AngII inhibited insulin-stimulated glucose uptake in NG cells; insulin had no effect in HG cells.
• AngII modulated glucose transporter expression and increased podocyte insulin receptor levels, mediated by PKC and PI3K.

Conclusions:

• Angiotensin II plays a significant role in modulating glucose uptake in podocytes.
• AngII regulates glucose transporters and insulin signaling pathways, contributing to podocyte dysfunction in diabetic conditions.